OGN

Dopo l'orario di chiusura: 13.72

Organon Co (OGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Organon Co Stock (OGN) Company Profile

Healthcare (1064)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Prossima data di guadagno

Ultimi documenti SEC

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OGN Organon Co	13.72	3.61B	6.16B	246.00M	708.00M	0.9387
LLY Lilly Eli Co	1,142.85	1.02T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	256.03	623.34B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	262.82	459.33B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	144.30	367.07B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	141.00	276.48B	54.66B	13.58B	16.05B	7.0171

Organon Co Stock (OGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Underweight
2025-10-27	Downgrade	Piper Sandler	Overweight → Underweight
2025-05-02	Downgrade	Evercore ISI	Outperform → In-line
2024-09-06	Downgrade	JP Morgan	Neutral → Underweight
2023-11-03	Downgrade	Goldman	Buy → Neutral
2023-09-21	Iniziato	Barclays	Overweight
2023-03-16	Iniziato	Raymond James	Outperform
2022-10-14	Downgrade	BofA Securities	Neutral → Underperform
2022-09-06	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-08-05	Downgrade	BofA Securities	Buy → Neutral
2022-04-27	Iniziato	Goldman	Buy
2022-04-06	Ripresa	Morgan Stanley	Equal-Weight
2021-10-07	Iniziato	Piper Sandler	Neutral
2021-09-01	Iniziato	BofA Securities	Buy
2021-07-22	Iniziato	Citigroup	Buy
2021-06-15	Iniziato	JP Morgan	Neutral
2021-06-11	Iniziato	Morgan Stanley	Equal-Weight
2021-06-10	Iniziato	Evercore ISI	Outperform

Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

Organon Co Azioni (OGN) Dati Finanziari

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, MRK, NVS

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Borsa (OGN) Ultime notizie

Organon presents VTAMA analysis: Organon stock gains 1.16 percent - AD HOC NEWS

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference - Business Wire

Organon & Co. (OGN) Stock Forecasts - Yahoo Finance

Tangible book value per share of Organon & Co. – HAN:7XP - TradingView

Organon & Co. Revenue Breakdown – HAN:7XP - TradingView

Sun Pharma plans $1 billion local debt sale for loan takeout, sources say - ETPharma.com

Sun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: Report - NDTV Profit

Sun Pharma plans $1 billion rupee debt sale to refinance Organon acquisition loan - Firstpost

Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis - marketscreener.com

Sun Pharma’s Biggest Global Bet, Buys Organon in $11.75 Billion Deal; Pharma Stock Surge 7%Time to Buy? - goodreturns.in

Organon & Co. (OGN) Stock forecasts - Yahoo Finance Singapore

Precision Trading with Organon & Co. (OGN) Risk Zones - Stock Traders Daily

Why Organon (OGN) Is Getting Attention Today - Yahoo Finance

Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device - Yahoo Finance

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

Organon (OGN) Looks 22% Overvalued Following The MIUDELLA FDA Filing - simplywall.st

Class A Dig — Organon/Sun Pharma premature-close (May ACQ deleted; early-2027 expected) - app.dealroom.co

Organon (OGN) Wins FDA Review Acceptance For New Hormone Free Contraceptive - simplywall.st

how InvestingPro spotted Organon’s 65% gain in healthcare sector By Investing.com - Investing.com Canada

Organon Backs Women’s Health Efforts Across India - pharmacy.biz

Organon Korea, Boryung expand Atozet tie-up to co-promotion - koreabiomed.com

Organon & Co. Common Stock (NY: OGN - The Chronicle-Journal

ORGANON & CO.MIUDELLA ANTICIPATED TO BE COMMERCIALLY AVAILABLE IN LATE 2026 - Moomoo

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA - Business Wire

Responsive Playbooks and the OGN Inflection - Stock Traders Daily

Organon: A Merger-Arbitrage Hold With Limited Upside - Seeking Alpha

OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits

Sun Pharma Gets Investment-Grade Ratings From Moody's, S&P for USD 11.75 Bn Organon Deal - Medical Dialogues

Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid - Business Standard

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Sun Pharma receives ratings boost over USD 11.75-billion Organon acqui - Daily Pioneer

Sun Pharma Gets Ratings Boost From Moody's, S&P Over $11.75-Bn Organon & Co Acquisition Bid - outlookbusiness.com

Sun Pharma gets ratings boost from Moody's, S&P over ₹11.75-billion Organon & Co acquisition bid - BusinessLine

Sun Pharma gets ratings boost from Moody's, S&P over $11.75 bn Organon & Co acquisition bid - ET Manufacturing

Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid - The Economic Times

Sun Pharma Gets Ratings Boost After Organon Acquisition Bid - Rediff MoneyWiz

Organon & Co. (OGN) Edges Up 0.15% to $13.78 as Shares Trade Between Key Support and ResistanceExtension Target - careplusvn.com

Organon & Co stock hits 52-week high at $13.78 By Investing.com - Investing.com Nigeria

Organon & Co stock hits 52-week high at $13.78 - Investing.com India

Henlius - henlius.com

Organon earnings up next: Can drugmaker rebound after Q1 miss? - investing.com

Organon (OGN) Move: Ends Up by 0.07% at $13.74 on the Day; Technical Setup: the $13.05 to $14.43 Range Remains in FocusBox Spread - Vinanet

Sun Pharma completes $11.75bn financing syndication for Organon acquisition - Generics and Biosimilars Initiative

Organon (OGN) Trading: Ends Up by 0.37% at $13.73 at the Close; Next Session: the Supplied Trading Band Runs From $13.04 to $14.42 under the Current SnapshotOvernight Profile - Vinanet

Organon & Co stock hits 52-week high at 13.73 USD - Investing.com

Organon & Co. (NYSE:OGN) Reaches New 12-Month HighStill a Buy? - MarketBeat

Orographic Financial Advisors, LLC's Organon & Co(OGN) Holding History - GuruFocus

how InvestingPro’s Fair Value spotted Organon’s 69% gain potential By Investing.com - Investing.com South Africa

Organon Co Azioni (OGN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a OGN